Chromadex Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ChromaDex Co (NASDAQ:CDXC) Expected to Earn Q1 2025 Earnings of $0 00 Per Share

ChromaDex Co (NASDAQ:CDXC) Expected to Earn Q1 2025 Earnings of $0 00 Per Share
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Roth mkmSilverberg bernstein capital managementSg americas securitiesGabelli fundsChromadex coChromadex company profileConnor clark lunn investment management ltdChromadex corporationInternational assets investment managementFree reportRoth capitalAssets investment managementBernstein capital managementLunn investment managementGet free reportXidex corporation

ChromaDex s (CDXC) Buy Rating Reiterated at HC Wainwright

ChromaDex s (CDXC) Buy Rating Reiterated at HC Wainwright
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Roth mkmInternational assets investment managementSg americas securitiesGabelli fundsChromadex company profileConnor clark lunn investment management ltdChromadex corporationSilverberg bernstein capital managementGet free reportAssets investment managementBernstein capital managementLunn investment managementXidex corporationAnalytical reference standardsChromadex daily

HC Wainwright Reaffirms Buy Rating for ChromaDex (NASDAQ:CDXC)

HC Wainwright Reaffirms Buy Rating for ChromaDex (NASDAQ:CDXC)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Roth mkmGabelli fundsInternational assets investment managementChromadex corporationConnor clark lunn investment management ltdSilverberg bernstein capital managementGamco investorsGet free reportLunn investment managementBernstein capital managementAssets investment managementXidex corporationAnalytical reference standardsChromadex daily

ChromaDex (NASDAQ:CDXC) PT Raised to $6 00

ChromaDex (NASDAQ:CDXC – Get Free Report) had its price objective hoisted by stock analysts at Roth Mkm from $4.25 to $6.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Roth Mkm’s price objective points to a potential upside of 44.58% […]

United kingdomRoth mkmChromadex corporationTopco ltdVanguard group incJpmorgan chase coCambridge investment research advisors incRenaissance technologiesGet free reportInvestment research advisorsXidex corporationAnalytical reference standardsChromadex daily

Analyzing FitLife Brands (NASDAQ:FTLF) and ChromaDex (NASDAQ:CDXC)

ChromaDex (NASDAQ:CDXC – Get Free Report) and FitLife Brands (NASDAQ:FTLF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Profitability This table compares ChromaDex and FitLife Brands’ […]

United statesLos angelesChromadex corporationFitlife brands incBond laboratories incGet free reportFitlife brandsFitlife brandGiven chromadexLife brandsXidex corporationAnalytical reference standardsMetis nutritionBiogenetic laboratoriesBond laboratoriesChromadex daily